BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiani A, Narayanan S, Pena L, Friedman M. The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer. Cancer Control 2017;24:1073274817729240. [PMID: 28975833 DOI: 10.1177/1073274817729240] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Ali S, Haque N, Azhar Z, Saeinasab M, Sefat F. Regenerative Medicine of Liver: Promises, Advances and Challenges. Biomimetics (Basel) 2021;6:62. [PMID: 34698078 DOI: 10.3390/biomimetics6040062] [Reference Citation Analysis]
2 Chen J, Rong X, Liu X, Zheng D, Rong X, Chen F, Zhao P, Liu F, Ruan J. FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma. Cancer Cell Int 2020;20:196. [PMID: 32508532 DOI: 10.1186/s12935-020-01265-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ma Z, Zhang B, Fan Y, Wang M, Kebebe D, Li J, Liu Z. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomed Pharmacother 2019;117:109128. [PMID: 31234023 DOI: 10.1016/j.biopha.2019.109128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
4 Hou ZB, Zhao F, Zhang B, Zhang CZ. Study on clinical application of susceptibility weighted imaging ombined with diffusion weighted imaging in patients with Liver Cirrhosis complicated with small Hepatocellular Carcinoma. Pak J Med Sci 2021;37:800-4. [PMID: 34104168 DOI: 10.12669/pjms.37.3.3822] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Diniz PHC, Silva SDDC, Faria LC, Vidigal PVT, Ferrari TCA. Clinical and laboratory parameters as predictors of long-term outcome according to the etiology of underlying chronic liver disease in patients who underwent liver transplantation for hepatocellular carcinoma treatment. Clinics (Sao Paulo) 2020;75:e1529. [PMID: 32520221 DOI: 10.6061/clinics/2020/e1529] [Reference Citation Analysis]
6 Plahuta I, Jelenko M, Potrč S, Ivanecz A. Abandonment of surveillance, followed by emergency surgery for a second spontaneous rupture of hepatocellular carcinoma: A case report and review of the literature. Clin Case Rep 2019;7:789-96. [PMID: 30997087 DOI: 10.1002/ccr3.2097] [Reference Citation Analysis]
7 Piñeiro Fernández J, Luddy KA, Harmon C, O'Farrelly C. Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function. Int J Mol Sci 2019;20:E4131. [PMID: 31450598 DOI: 10.3390/ijms20174131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
8 Liu K, Huang G, Chang P, Zhang W, Li T, Dai Z, Lv Y. Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients. Sci Rep 2020;10:21376. [PMID: 33288828 DOI: 10.1038/s41598-020-78545-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhang S, Zhao G, Dong H. Effect of Radiofrequency Ablation with Interventional Therapy of Hepatic Artery on the Recurrence of Primary Liver Cancer and the Analysis of Influencing Factors. J Oncol 2021;2021:3392433. [PMID: 34691177 DOI: 10.1155/2021/3392433] [Reference Citation Analysis]
10 Zhang Z, Li JW, Zeng PH, Gao WH, Tian XF. Data Mining and Systems Pharmacology to Elucidate Effectiveness and Mechanisms of Chinese Medicine in Treating Primary Liver Cancer. Chin J Integr Med 2021. [PMID: 34432201 DOI: 10.1007/s11655-021-3449-8] [Reference Citation Analysis]
11 Fu X, Tang Y, Wu W, Ouyang Y, Tan D, Huang Y. Exosomal microRNA-25 released from cancer cells targets SIK1 to promote hepatocellular carcinoma tumorigenesis. Dig Liver Dis 2021:S1590-8658(21)00385-6. [PMID: 34384713 DOI: 10.1016/j.dld.2021.07.017] [Reference Citation Analysis]
12 Uzzaman A, Zhang X, Qiao Z, Zhan H, Sohail A, Wahid A, Shang Z, Guan X, Cao CX, Xiao H. Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer. Biochimie 2020;177:132-41. [PMID: 32835735 DOI: 10.1016/j.biochi.2020.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ye H, Zhou L, Jin H, Chen Y, Cheng D, Jiang Y. Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy. Biomed Res Int 2020;2020:1351046. [PMID: 32461962 DOI: 10.1155/2020/1351046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lv R, Tian Y, Yu Z, Liu C. Clinical efficacy of computed tomography-guided microwave ablation sequential transcatheter arterial chemoembolization under edge calculation for primary liver cancer over 5 cm in diameter. J Supercomput. [DOI: 10.1007/s11227-021-04118-3] [Reference Citation Analysis]
15 Li Z, Liu Y, Yan J, Zeng Q, Hu Y, Wang H, Li H, Li J, Yu Z. Circular RNA hsa_circ_0056836 functions an oncogenic gene in hepatocellular carcinoma through modulating miR-766-3p/FOSL2 axis. Aging (Albany NY) 2020;12:2485-97. [PMID: 32048611 DOI: 10.18632/aging.102756] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
16 Luo Y, Zhang J, Fang L, Zhu Y, You Y, Zhang C, Zheng P, Zhang L, Yin L, Xia F, Bie P, Xie C. FBXW10 promotes hepatocarcinogenesis in male patients and mice. Carcinogenesis 2020;41:689-98. [DOI: 10.1093/carcin/bgz138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 van Tienderen GS, Groot Koerkamp B, IJzermans JNM, van der Laan LJW, Verstegen MMA. Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment. Cancers (Basel). 2019;11. [PMID: 31683901 DOI: 10.3390/cancers11111706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
18 Diniz PHC, Silva SDC, Vidigal PVT, Xavier MAP, Lima CX, Faria LC, Ferrari TCA. Expression of MAPK and PI3K/AKT/mTOR Proteins according to the Chronic Liver Disease Etiology in Hepatocellular Carcinoma. J Oncol 2020;2020:4609360. [PMID: 33178273 DOI: 10.1155/2020/4609360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Selvaggi F, Catalano T, Cotellese R, Aceto GM. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents. Cancers 2022;14:1912. [DOI: 10.3390/cancers14081912] [Reference Citation Analysis]
20 Li C, Zhang W, Yang H, Xiang J, Wang X, Wang J. Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma. PeerJ 2020;8:e8758. [PMID: 32201648 DOI: 10.7717/peerj.8758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang J, Wang Z, Yuan J, Wang J, Shen X. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma. Aging (Albany NY) 2020;12:7786-800. [PMID: 32357142 DOI: 10.18632/aging.103092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang Z, Wang S, Yang F, Meng Z, Liu Y. LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer. Oncol Rep 2020;43:55-74. [PMID: 31746401 DOI: 10.3892/or.2019.7398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Zhang Y, Ying X, Zhao Q, Ma J, Zhang D, He C, Han S. Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ. Dis Markers 2020;2020:2632716. [PMID: 32076459 DOI: 10.1155/2020/2632716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. J Egypt Natl Canc Inst 2020;32:5. [PMID: 32372179 DOI: 10.1186/s43046-020-0016-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
25 Cai Y, Jia Y. Circular RNA SOX5 promotes the proliferation and inhibits the apoptosis of the hepatocellular carcinoma cells by targeting miR-502-5p/synoviolin 1 axis. Bioengineered 2022;13:3362-70. [PMID: 35048790 DOI: 10.1080/21655979.2022.2029110] [Reference Citation Analysis]
26 Huang X, Shu C, Chen L, Yao B. Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer. Oncol Rep 2018;40:1359-69. [PMID: 29956810 DOI: 10.3892/or.2018.6529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
27 Ouyang Y, Tang Y, Fu L, Peng S, Wu W, Tan D, Fu X. Exosomes secreted by chronic hepatitis B patients with PNALT and liver inflammation grade ≥ A2 promoted the progression of liver cancer by transferring miR-25-3p to inhibit the co-expression of TCF21 and HHIP. Cell Prolif 2020;53:e12833. [PMID: 32525231 DOI: 10.1111/cpr.12833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
28 Ye M, Wang S, Qie JB, Sun PL. SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Front Oncol 2021;11:765484. [PMID: 34671565 DOI: 10.3389/fonc.2021.765484] [Reference Citation Analysis]
29 Su D. The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma. Bioengineered 2021;12:11124-35. [PMID: 34923912 DOI: 10.1080/21655979.2021.2001239] [Reference Citation Analysis]
30 Rah B, Rather RA, Bhat GR, Baba AB, Mushtaq I, Farooq M, Yousuf T, Dar SB, Parveen S, Hassan R, Mohammad F, Qassim I, Bhat A, Ali S, Zargar MH, Afroze D. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies. Front Pharmacol 2022;13:821344. [DOI: 10.3389/fphar.2022.821344] [Reference Citation Analysis]
31 You J, Gong Y, Wu Y, Jin L, Chi Q, Sun D. WGCNA, LASSO and SVM Algorithm Revealed RAC1 Correlated M0 Macrophage and the Risk Score to Predict the Survival of Hepatocellular Carcinoma Patients. Front Genet 2022;12:730920. [DOI: 10.3389/fgene.2021.730920] [Reference Citation Analysis]
32 Luo Y, Zhang YJ, Zhang DM, Yishake D, Liu ZY, Chen MS, Wang F, Zhou ZG, Long JA, Zhong RH, Chen S, Lu XT, Li SY, He TT, Luo Y, Fang AP, Zhu HL. Association between dietary patterns and prognosis of hepatocellular carcinoma in the Guangdong liver cancer cohort study. Hepatol Res 2020;50:1164-75. [PMID: 32691459 DOI: 10.1111/hepr.13548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 De Sanctis V, Soliman AT, Daar S, Alansary N, Kattamis A, Skafida M, Galati MC, Christou S, Campisi S, Messina G, Yassin MA, Canatan D, Di Maio S, Al Jaouni S, Raiola G, Karimi M, Kaleva V, Kakkar S, Mariannis D, Kattamis C. A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience. Mediterr J Hematol Infect Dis 2020;12:e2020006. [PMID: 31934316 DOI: 10.4084/MJHID.2020.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ye C, Zhang W, Pang Z, Wang W. Efficacy of liver cancer microwave ablation through ultrasonic image guidance under deep migration feature algorithm. Pak J Med Sci 2021;37:1693-8. [PMID: 34712308 DOI: 10.12669/pjms.37.6-WIT.4885] [Reference Citation Analysis]
35 Ye Z, He Q, Wang Q, Lin Y, Cen K, Chen X. LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5. Mol Cell Biochem 2021;476:3757-69. [PMID: 34097192 DOI: 10.1007/s11010-021-04196-0] [Reference Citation Analysis]
36 Guo Z, Chen W, Dai G, Huang Y. Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4. Int J Mol Med 2020;45:141-50. [PMID: 31746344 DOI: 10.3892/ijmm.2019.4391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Wang Y, Xu B, Zhou J, Wu X. Propofol activates AMPK to inhibit the growth of HepG2 cells in vitro and hepatocarcinogenesis in xenograft mouse tumor models by inducing autophagy. J Gastrointest Oncol 2020;11:1322-32. [PMID: 33457004 DOI: 10.21037/jgo-20-472] [Reference Citation Analysis]